Evidence map›Paper›PMID 42768292›Full record

ArticleStatistics in medicine2026

A Neutral Comparison of Multivariate Hypothesis Tests for Parallel Group Designs in Rare Disease Settings.

Martin Geroldinger, Martin Laimer, Verena Wally, Johann W Bauer, Georg Zimmermann

Abstract readComparative Study
In one paragraph

Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Martin GeroldingerResearch Program Biomedical Data Science, Paracelsus Medical University, Salzburg, Austria.ORCID https://orcid.org/0000-0002-7858-323X
Martin LaimerDepartment of Dermatology and Allergology, Paracelsus Medical University, Salzburg, Austria.
Verena WallyDepartment of Dermatology and Allergology, Paracelsus Medical University, Salzburg, Austria.ORCID https://orcid.org/0000-0001-8705-3890
Johann W BauerDepartment of Dermatology and Allergology, Paracelsus Medical University, Salzburg, Austria.ORCID https://orcid.org/0000-0002-6085-9170
Georg ZimmermannResearch Program Biomedical Data Science, Paracelsus Medical University, Salzburg, Austria.ORCID https://orcid.org/0000-0002-8282-1034

Funding

EXDIGIT 20204-WISS/263/6-6022HORIZON-HLTH-2023-DISEASE-07-01 101156595IDA-Lab Salzburg 20102-F1901166-KZPIDA-Lab Salzburg 20204-WISS/225/197-2019Innovative Health Initiative 101165912Salzburger Landesregierung (WISS 2025 project"servEB") 20102/F2300645-FPR
6 · The paper itself

Abstract

Multivariate endpoints are increasingly used in clinical studies on rare diseases, where sample sizes tend to be small and distributional assumptions are often violated. In such settings, commonly applied parametric multivariate methods, such as classical MANOVA approaches, may suffer from inflated type-I error or reduced statistical power. Therefore, a neutral simulation-based comparison of four methodologically different approaches for the analysis of multivariate outcomes in parallel group designs was conducted. The four approaches included the nonparametric R package npmv (using permutation and randomization resampling for small samples), a semiparametric MANOVA approach from the R package MANOVA.RM with both a Wald-type statistics (WTS) and a modified ANOVA-type statistics (MATS) using all available variants including also bootstrap approaches, a classical parametric MANOVA, and multiple univariate Mann-Whitney tests with Holm correction. The simulation framework was informed by empirical distributions derived from anonymized clinical data and clinical expert guidance. Two clinically realistic effect types were mainly evaluated: (i) percent-responder effects for wound size reduction and (ii) additional location shifts in pain and pruritus visual analog scales (VAS) scores. In addition, scenarios are examined in which classical assumptions such as multivariate normality and homogeneity of covariance matrices are violated. The sample sizes considered ranged from 12 to 360 subjects. Both balanced and unbalanced designs were evaluated, with the objective of illustrating potential limitations of methods when applied to small samples. Outcomes were assessed in terms of type-I error control and statistical power. Overall, npmv, the MATS using especially parametric bootstrap within the semiparametric MANOVA.RM package maintained reliable type-I error control, whereas the semiparametric MANOVA.RM approach with the WTS using its asymptotic approximation showed very liberal type-I error behavior to almost no type-I error control in small sample scenarios, and especially in unbalanced settings. Bootstrap approaches especially of the WTS substantially improved type-I error control compared with the asymptotic WTS. The nonparametric npmv approach achieved good power values, especially in small samples, as did the modified ATS approach using parametric bootstrap from the MANOVA.RM package, which achieved very similar results. The univariate Mann-Whitney U test with Holm correction tended to yield conservative results for small samples; however, despite the univariate nature of this approach, it achieved a high and comparable level of statistical power in many scenarios. Classical MANOVA also yielded good results in certain scenarios; however, it exhibited rather liberal type-I error rates, primarily in heteroscedastic scenarios and unbalanced designs, which can be explained by a violation of the assumption of homoscedastic covariance matrices. These results highlight the strengths and limitations of a multi-aspect analysis in parallel group designs especially for small sample settings, as common in rare diseases, and provide guidance for the analysis in rare disease research.

Indexed as

Rare DiseasesComputer SimulationHumansModels, StatisticalMultivariate AnalysisResearch DesignSample SizeMANOVA.RMmulti‐aspect modelingmultivariate statisticsneutral comparisonnpmvparallel‐group designrare diseases

Identifiers

PMID42768292
PMCPMC13593806

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.